Trials / Completed
CompletedNCT01361048
Neo-Penotran Forte Vaginal Suppository for Vaginal Trichomoniasis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- University of Alabama at Birmingham · Academic / Other
- Sex
- Female
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The investigators are trying a combination vaginal product of higher dose metronidazole combined with miconazole to see if it is effective in treating vaginal trichomonas.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | oral metronidazole | 2 gm oral once |
| DRUG | neo penotran forte | neo penotran forte intravaginal twice a day for 7 days |
| DRUG | neo penotran forte once a day | neo penotran forte intravaginally once a day for 7 days |
Timeline
- Start date
- 2011-12-01
- Primary completion
- 2012-08-01
- Completion
- 2013-01-01
- First posted
- 2011-05-26
- Last updated
- 2018-01-19
- Results posted
- 2014-02-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01361048. Inclusion in this directory is not an endorsement.